XML 38 R15.htm IDEA: XBRL DOCUMENT
v3.25.0.1

STOCK OPTIONS AND AWARDS | 12 Months Ended
--- | ---
Dec. 28, 2024
STOCK OPTIONS AND AWARDS |
STOCK OPTIONS AND AWARDS | 7. STOCK OPTIONS AND AWARDS Stock Awards As of December 28, 2024, the Company has one incentive stock award plan, The Eastern Company 2020 Stock Incentive Plan (the “2020 Plan”), for officers, other key employees, and non-employee directors. Incentive stock awards granted under the 2020 Plan must have exercise prices that are not less than 100% of the fair market value of the Company’s common stock on the dates the stock awards are granted. Restricted stock awards may also be granted to participants under the 2020 Plan with restrictions determined by the Compensation Committee of the Company’s Board of Directors. Under the 2020 Plan, non-qualified stock awards granted to participants will have exercise prices determined by the Compensation Committee of the Company’s Board of Directors. The Company granted 92,016 and 82,800 awards during 2024 and 2023, respectively. The 2020 Plan also permits the issuance of Stock Appreciation Rights (“SARs”). The SARs are in the form of an award with a cashless exercise price equal to the difference between the fair value of the Company’s common stock at the date of grant and the fair value as of the exercise date resulting in the issuance of the Company’s common stock. The Company issued 53,568 and 0 SARs in 2024 and 2023, respectively. For the period of 2024, the Company used several assumptions which included an expected term of 3 years, volatility deviation of 38.30% and a risk-free rate of 4.51%. Stock-based compensation expense/(income), including forfeitures, in connection with stock awards and SARs previously granted to employees was $1,030,000 and $(74,277) for fiscal years 2024 and 2023, respectively. The Company used fair market value to determine the associated expense with stock awards for the 2024 and 2023 fiscal years. As of December 28, 2024, there were 854,482 shares of common stock reserved and available for future grant under 2020 Plan. The following tables set forth the outstanding SARs for the period specified:
|  | Year Ended December 28, 2024 |  |  | Year Ended December 30, 2023 |
|  | Units |  |  | Weighted - Average Exercise Price |  |  | Units |  |  | Weighted - Average Exercise Price |
Outstanding at beginning of period |  |  | 13,000 |  |  | $ | 24.19 |  |  |  | 146,166 |  |  | $ | 23.22 |
Issued |  |  | 53,568 |  |  |  | 28.69 |  |  |  | - |  |  |  | - |
Expired |  |  | (9,000 | ) |  |  | 26.30 |  |  |  | (50,833 | ) |  |  | 24.24 |
Exercised |  |  | (2,500 | ) |  |  | 20.20 |  |  |  | (33,333 | ) |  |  | 21.10 |
Forfeited |  |  | (29,952 | ) |  |  | 28.69 |  |  |  | (49,000 | ) |  |  | 22.80 |
Outstanding at end of period |  |  | 25,116 |  |  |  | 28.18 |  |  |  | 13,000 |  |  |  | 24.19 |
SARs Outstanding and Exercisable
Range of Exercise Prices |  | Outstanding as of December 28, 2024 |  |  | Weighted- Average Remaining Contractual Life |  |  | Weighted- Average Exercise Price |  |  | Exercisable as of December 28, 2024 |  |  | Weighted- Average Remaining Contractual Life |  |  | Weighted- Average Exercise Price |
$20.20 - $28.69 |  |  | 25,116 |  |  |  | 4.3 |  |  | $ | 28.18 |  |  |  | 1,500 |  |  |  | 0.3 |  |  | $ | 20.20 |
The following tables set forth the outstanding stock grants for the period specified:
|  | Year Ended December 24, 2024 |  |  | Year Ended December 30, 2023 |
|  | Shares |  |  | Shares |
Outstanding at beginning of period |  |  | 89,400 |  |  |  | 64,500 |
Issued |  |  | 38,448 |  |  |  | 82,800 |
Exercised |  |  | (38,534 | ) |  |  | (10,600 | )
Forfeited |  |  | (49,722 | ) |  |  | (47,300 | )
Outstanding at end of period |  |  | 39,592 |  |  |  | 89,400 |
As of December 28, 2024, outstanding SARs and awards had an intrinsic value of $1,062,000.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration